Status:
RECRUITING
Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy
Lead Sponsor:
Umeå University
Conditions:
Tonsillectomy
Pain
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
Betamethasone is currently given routinely in conjunction with tonsillectomy surgery at the majority of Ear, Nose \& Throat clinics in Sweden. The scientific evidence regarding the effects of betameth...
Detailed Description
Steroids are used routinely aiming to reduce pain and nausea, especially in surgery with high levels of postoperative pain. The majority of international studies on tonsillectomy (TE) are performed on...
Eligibility Criteria
Inclusion
- Signed informed consent Age over 12 years Planned for elective bilateral tonsillectomy
Exclusion
- • Insulin dependent diabetes mellitus
- NSAID or corticosteroid intolerance
- Pregnancy
- Gastric ulcer
- Immunodeficiency
- Treatment for chronic pain
- Psychiatric disorders
Key Trial Info
Start Date :
September 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03783182
Start Date
September 10 2019
End Date
December 15 2025
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunderby sjukhus
Luleå, Sweden, 971 80